Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML
吉妥珠单抗奥佐米星联合阿糖胞苷、柔红霉素和米哚妥林诱导治疗FLT3突变型急性髓系白血病的安全性
期刊:
影响因子:
doi:10.1016/j.bneo.2025.100171
Jain, Jayanshu; Pugh, Kelly; Handa, Shivani; Dvorak-Kornaus, Kaitlyn M; Zhao, Qiuhong; Walter, Roland B; Cook, Rachel; Saultz, Jennifer; Swords, Ronan; Li, Junyang; Laszlo, George S; Grieselhuber, Nicole R; Mims, Alice S; Larkin, Karilyn T M; Sahasrabudhe, Kieran; Blachly, James S; Behbehani, Gregory K; Eisfeld, Ann-Kathrin; Long, Meixiao; Srisuwananukorn, Andrew; Koenig, Kristin L; Borate, Uma